Drug intelligence / Profile preview

11C-acetoacetate

Development stage
Unknown
Lead developer
Université de Sherbrooke
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

11C-acetoacetate is a positron emission tomography (PET) radiopharmaceutical used as a metabolic tracer to quantify the uptake and utilization of ketone bodies in vivo. As a radiolabeled analog of the naturally occurring ketone body acetoacetate, it is transported into cells—primarily in the brain, heart, and kidneys—via monocarboxylate transporters (MCTs). Once intracellular, it enters the ketolysis pathway where it is converted into acetoacetyl-CoA by the enzyme succinyl-CoA:3-ketoacid CoA transferase (SCOT) and subsequently metabolized in the mitochondria. This tracer is particularly valuable in neuroimaging research to study brain energy metabolism in neurodegenerative conditions like Alzheimer's disease, where glucose metabolism is often impaired but ketone utilization may be preserved or altered. It is also used to investigate myocardial metabolism and the metabolic shifts associated with ketogenic diets or diabetes.

Other names
Carbon-11 acetoacetateCarbon11 acetoacetateCarbon 11 acetoacetate11C-labeled acetoacetate
02

Targets

OXCT1 (Succinyl-CoA:3-ketoacid CoA-transferase 1)MCT2 (Monocarboxylate transporter 2)SLC16A1 (Mitochondrial Pyruvate Carrier)

Beyond the preview

Go deeper on 11C-acetoacetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 11C-acetoacetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call